Business Standard

Wockhardt Q3 results: Loss narrows to Rs 86 cr, revenue up marginally

The company had incurred a loss of Rs 102 crore in the third quarter last fiscal, Wockhardt Ltd said in a regulatory filing

pharmaceutical sector, pharma sector, medicines, meds

Total expenses were lower at Rs 796 crore as against Rs 803 crore in the same period last fiscal| Photo: Bloomberg

Press Trust of India New Delhi

Listen to This Article

Pharmaceuticals firm Wockhardt Ltd on Wednesday reported narrowing of consolidated net loss to Rs 86 crore for the third quarter ended December 31, 2023.
The company had incurred a loss of Rs 102 crore in the third quarter last fiscal, Wockhardt Ltd said in a regulatory filing.
Revenue from operations during the quarter under review stood at Rs 701 crore as compared to Rs 699 crore in the year-ago period, the company said.
Total expenses were lower at Rs 796 crore as against Rs 803 crore in the same period last fiscal.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Feb 14 2024 | 3:39 PM IST

Explore News